{"name":"S.R. One","permalink":"s-r-one","crunchbase_url":"http://www.crunchbase.com/financial-organization/s-r-one","homepage_url":"http://www.srone.com/","blog_url":"","blog_feed_url":"","twitter_username":"","phone_number":"610.567.1000","description":"venture capital arm of GlaxoSmithKline","email_address":"","number_of_employees":null,"founded_year":null,"founded_month":null,"founded_day":null,"tag_list":null,"alias_list":"","created_at":"Fri Apr 17 16:17:04 UTC 2009","updated_at":"Thu Oct 01 13:18:48 UTC 2009","overview":"<p>SR One is the corporate venture capital arm of GlaxoSmithKline. The firm invests globally in emerging life science companies that are pursuing innovative science which will significantly impact medical care.</p>","image":{"available_sizes":[[[150,54],"assets/images/resized/0005/5107/55107v2-max-150x150.jpg"],[[205,74],"assets/images/resized/0005/5107/55107v2-max-250x250.jpg"],[[205,74],"assets/images/resized/0005/5107/55107v2-max-450x450.jpg"]],"attribution":null},"offices":[{"description":"Headquarters","address1":"161 Washington Street ","address2":"Suite 500","zip_code":"19428-2077","city":"Conshohocken","state_code":"PA","country_code":"USA","latitude":40.071356,"longitude":-75.307653}],"relationships":[],"investments":[{"funding_round":{"round_code":"unattributed","source_url":"http://www.rib-x.com/news_and_events/release_2009_01_26","source_description":"Rib-X Pharmaceuticals Announces Positive Phase 2 Study Results for Delafloxacin and a $25 Million Financing","raised_amount":25000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":1,"funded_day":25,"company":{"name":"Rib-X Pharmaceuticals","permalink":"rib-x-pharmaceuticals","image":{"available_sizes":[[[150,49],"assets/images/resized/0004/1688/41688v1-max-150x150.png"],[[250,82],"assets/images/resized/0004/1688/41688v1-max-250x250.png"],[[282,93],"assets/images/resized/0004/1688/41688v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://venturebeat.com/2007/07/31/calcimedica-raises-15m-for-inflammatory-disease/","source_description":"CalciMedica raises $1.5M for inflammatory disease","raised_amount":1500000,"raised_currency_code":"USD","funded_year":2007,"funded_month":7,"funded_day":31,"company":{"name":"CalciMedica","permalink":"calcimedica","image":{"available_sizes":[[[150,35],"assets/images/resized/0004/8731/48731v1-max-150x150.jpg"],[[248,58],"assets/images/resized/0004/8731/48731v1-max-250x250.jpg"],[[248,58],"assets/images/resized/0004/8731/48731v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.biospace.com/News/applied-genetic-technologies-corporation-lands-37/280113/Source=TopBreaking","source_description":"Applied Genetic Technologies Corporation Lands $37.5 Million in Venture Capital Funding","raised_amount":37500000,"raised_currency_code":"USD","funded_year":2012,"funded_month":11,"funded_day":19,"company":{"name":"Applied Genetics Technologies Corporation","permalink":"applied-genetics-technologies-corporation","image":{"available_sizes":[[[133,150],"assets/images/resized/0004/8997/48997v1-max-150x150.png"],[[150,169],"assets/images/resized/0004/8997/48997v1-max-250x250.png"],[[150,169],"assets/images/resized/0004/8997/48997v1-max-450x450.png"]],"attribution":null}}}}],"milestones":[],"providerships":[],"funds":[],"video_embeds":[],"external_links":[]}